Dr. Kulvi Kaur, DPhil  joins EpigeneticsRx as its Chief Scientific Officer. Dr. Kaur is internationally recognized for her work at Oxford on the application of disruptive technologies in the healthcare industry. She was recruited to the USA Biotechnology Industry on an ‘Einstein Visa’ as an Alien of Extraordinary Abilities for this work. She has over 20 years of DNA laboratory sequencing experience, clinical and diagnostic expertise in areas of oncology and toxicity, is a published researcher, and holds pharmacogenomics patents.



Dr. Kulvi Kaur
Dr. Kulvi KaurDPhil